
Albert David Ltd Stock Hits 52-Week Low at Rs.686.45
2026-01-19 10:09:43Albert David Ltd, a player in the Pharmaceuticals & Biotechnology sector, recorded a fresh 52-week low of Rs.686.45 today, marking a significant decline amid a sustained downward trend over recent sessions.
Read full news article
Albert David Ltd Stock Falls to 52-Week Low of Rs.705
2026-01-14 11:16:56Albert David Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.705 today, marking a significant decline in its stock price amid ongoing downward momentum and underperformance relative to its sector and broader market indices.
Read full news article
Albert David Ltd is Rated Strong Sell
2026-01-14 10:10:21Albert David Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 14 January 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall market standing.
Read full news article
Albert David Ltd is Rated Strong Sell
2026-01-03 10:10:05Albert David Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 03 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Albert David Ltd Stock Falls to 52-Week Low of Rs.730.05
2025-12-30 09:54:48Albert David Ltd’s shares declined to a fresh 52-week low of Rs.730.05 on 30 Dec 2025, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s stock has underperformed its sector and broader market indices, reflecting persistent pressures on its financial performance and valuation metrics.
Read full news article
Albert David Stock Falls to 52-Week Low of Rs.738.95 Amidst Prolonged Downtrend
2025-12-26 10:44:31Albert David, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.738.95 today, marking a significant milestone in its ongoing price decline. This level reflects a continuation of the stock’s subdued performance over the past year, contrasting sharply with broader market trends.
Read full news article
Albert David Sees Revision in Market Evaluation Amid Challenging Financial Trends
2025-12-23 10:10:16Albert David, a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The recent assessment highlights shifts across key analytical parameters, signalling caution for investors amid subdued returns and operational pressures.
Read full news article
Albert David Stock Falls to 52-Week Low of Rs.740.25 Amidst Continued Downtrend
2025-12-16 14:15:12Albert David's shares reached a fresh 52-week low of Rs.740.25 today, marking a significant decline amid a sustained downward trend over recent sessions. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology industry.
Read full news article
Albert David Stock Falls to 52-Week Low of Rs.754.55 Amidst Prolonged Downtrend
2025-12-10 15:21:36Albert David, a company in the Pharmaceuticals & Biotechnology sector, recorded a new 52-week low of Rs.754.55 today, reflecting a continuation of its downward trajectory over the past year. The stock's performance contrasts sharply with broader market trends, underscoring ongoing challenges within the company’s financial results and market positioning.
Read full news articleAnnouncement under Regulation 30 (LODR)-Change in Management
17-Jan-2026 | Source : BSEChange in Senior Management Personnel-Disclosure under Reg. 30 read with Schedule III of SEBI (LODR) Reg. 2015
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
05-Jan-2026 | Source : BSESubmission of Compliance Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018
Closure of Trading Window
22-Dec-2025 | Source : BSEClosure of Trading Window from 1st January 2026 for declaration of Unaudited Financial Results for the third quarter and nine months period ended 31st December 2025
Corporate Actions
No Upcoming Board Meetings
Albert David Ltd has declared 50% dividend, ex-date: 25 Jul 25
No Splits history available
No Bonus history available
No Rights history available






